Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Nash

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 1, 2022
Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trialsAnju T Peters, Zachary M Soler, Robert C Kern, et al.
ERJ Open Research|December 1, 2022
AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polypsShahid Siddiqui, Claus Bachert, Adam M Chaker, et al.
Allergy|October 17, 2024
The IL-4-IL-4Rα axis modulates olfactory neuroimmune signaling to induce loss of smellYannis Hara, Mithilesh Kumar Jha, Jeremy Y Huang, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trialEugenio De Corso, G Walter Canonica, Enrico Heffler, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 1, 2022
Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trialsAnju T Peters, Zachary M Soler, Robert C Kern, et al.
ERJ Open Research|December 1, 2022
AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polypsShahid Siddiqui, Claus Bachert, Adam M Chaker, et al.
Allergy|October 17, 2024
The IL-4-IL-4Rα axis modulates olfactory neuroimmune signaling to induce loss of smellYannis Hara, Mithilesh Kumar Jha, Jeremy Y Huang, et al.
The Lancet. Respiratory Medicine|October 1, 2025
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trialEugenio De Corso, G Walter Canonica, Enrico Heffler, et al.
Pageof 5